These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32758572)

  • 1. Distinct effects on cAMP signaling of carbamazepine and its structural derivatives do not correlate with their clinical efficacy in epilepsy.
    Krarup S; Mertz C; Jakobsen E; Lindholm SEH; Pinborg LH; Bak LK
    Eur J Pharmacol; 2020 Nov; 886():173413. PubMed ID: 32758572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxcarbazepine and its active metabolite, (S)-licarbazepine, exacerbate seizures in a mouse model of genetic generalized epilepsy.
    Kim TH; Reid CA; Petrou S
    Epilepsia; 2015 Jan; 56(1):e6-9. PubMed ID: 25489632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxcarbazepine, an antiepileptic agent.
    Kalis MM; Huff NA
    Clin Ther; 2001 May; 23(5):680-700; discussion 645. PubMed ID: 11394728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, tolerability and effectiveness of transition to eslicarbazepine acetate from carbamazepine or oxcarbazepine in clinical practice.
    Rocamora R; Peltola J; Assenza G; McMurray R; Villanueva V
    Seizure; 2020 Feb; 75():121-128. PubMed ID: 31981862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of cyclic AMP production by carbamazepine.
    Chen G; Pan B; Hawver DB; Wright CB; Potter WZ; Manji HK
    J Neurochem; 1996 Nov; 67(5):2079-86. PubMed ID: 8863517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024.
    Ambrósio AF; Soares-Da-Silva P; Carvalho CM; Carvalho AP
    Neurochem Res; 2002 Feb; 27(1-2):121-30. PubMed ID: 11926264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders.
    Grant SM; Faulds D
    Drugs; 1992 Jun; 43(6):873-88. PubMed ID: 1379159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with partial-onset seizures.
    Perucca E; Elger C; Halász P; Falcão A; Almeida L; Soares-da-Silva P
    Epilepsy Res; 2011 Sep; 96(1-2):132-9. PubMed ID: 21680153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbamazepine-related antiepileptic drugs for the treatment of epilepsy - a comparative review.
    Gierbolini J; Giarratano M; Benbadis SR
    Expert Opin Pharmacother; 2016; 17(7):885-8. PubMed ID: 26999402
    [No Abstract]   [Full Text] [Related]  

  • 10. Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.
    Hebeisen S; Pires N; Loureiro AI; Bonifácio MJ; Palma N; Whyment A; Spanswick D; Soares-da-Silva P
    Neuropharmacology; 2015 Feb; 89():122-35. PubMed ID: 25242737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspects of cAMP Signaling in Epileptogenesis and Seizures and Its Potential as Drug Target.
    Mertz C; Krarup S; Jensen CD; Lindholm SEH; Kjær C; Pinborg LH; Bak LK
    Neurochem Res; 2020 Jun; 45(6):1247-1255. PubMed ID: 31414342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug.
    Doeser A; Dickhof G; Reitze M; Uebachs M; Schaub C; Pires NM; Bonifácio MJ; Soares-da-Silva P; Beck H
    Brain; 2015 Feb; 138(Pt 2):371-87. PubMed ID: 25472797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein.
    Zhang C; Zuo Z; Kwan P; Baum L
    Epilepsia; 2011 Oct; 52(10):1894-904. PubMed ID: 21692796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers.
    Milovan D; Almeida L; Romach MK; Nunes T; Rocha JF; Sokowloska M; Sellers EM; Soares-da-Silva P
    Epilepsy Behav; 2010 Aug; 18(4):366-73. PubMed ID: 20708576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers.
    Elger C; Bialer M; Falcão A; Vaz-da-Silva M; Nunes T; Almeida L; Soares-da-Silva P
    Epilepsia; 2013 Aug; 54(8):1453-61. PubMed ID: 23758485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbamazepine and oxcarbazepine, but not eslicarbazepine, enhance excitatory synaptic transmission onto hippocampal CA1 pyramidal cells through an antagonist action at adenosine A1 receptors.
    Booker SA; Pires N; Cobb S; Soares-da-Silva P; Vida I
    Neuropharmacology; 2015 Jun; 93():103-15. PubMed ID: 25656478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition from oxcarbazepine to eslicarbazepine acetate: A single center study.
    Mäkinen J; Rainesalo S; Peltola J
    Brain Behav; 2017 Mar; 7(3):e00634. PubMed ID: 28293474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eslicarbazepine acetate (BIA 2-093).
    Almeida L; Soares-da-Silva P
    Neurotherapeutics; 2007 Jan; 4(1):88-96. PubMed ID: 17199020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxic/neuroprotective profile of carbamazepine, oxcarbazepine and two new putative antiepileptic drugs, BIA 2-093 and BIA 2-024.
    Ambrósio AF; Silva AP; Araújo I; Malva JO; Soares-da-Silva P; Carvalho AP; Carvalho CM
    Eur J Pharmacol; 2000 Oct; 406(2):191-201. PubMed ID: 11020481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of eslicarbazepine acetate in the mouse after oral administration.
    Alves G; Figueiredo I; Castel-Branco M; Lourenço N; Falcão A; Caramona M; Soares-da-Silva P
    Fundam Clin Pharmacol; 2008 Oct; 22(5):529-36. PubMed ID: 18710399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.